Related Experiment Video
Updated: Aug 10, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Growth problems in children with asthma
1Children's Clinic Randers, Randers, Denmark. o.d.wolthers@dadlnet.dk
Insights
Children with asthma may experience growth problems, sometimes due to poor asthma control or corticosteroid treatments. Regular height monitoring is crucial for early detection and intervention in pediatric asthma patients.
Area of Science:
- Pediatric Endocrinology
- Respiratory Medicine
- Clinical Pediatrics
Background:
- Growth problems are a recognized concern in children with asthma.
- Poorly controlled asthma can rarely lead to significant growth issues.
- Delayed growth and puberty are observed in some asthmatic boys aged 8-15 years.
Purpose of the Study:
- To review the impact of asthma and its treatments on pediatric growth.
- To identify factors influencing growth suppression in asthmatic children.
- To provide guidelines for monitoring growth in children with asthma.
Main Methods:
- Literature review on asthma, corticosteroid therapy, and growth.
- Analysis of growth patterns in asthmatic pediatric populations.
- Evaluation of corticosteroid dose-response relationships for growth suppression.
Main Results:
- Systemic corticosteroids consistently suppress growth rate during treatment.
- Inhaled corticosteroids pose a risk of growth suppression, dependent on dose and delivery device (e.g., budesonide >800 mcg MDI with spacer, >400 mcg DPI; fluticasone propionate >400 mcg DPI).
- Chronic growth delay and pubertal delay are associated with poor asthma control in some boys.
Conclusions:
- Asthma management requires careful consideration of potential growth impacts.
- Regular height monitoring (every 6 months) is essential for all children with asthma.
- Endocrine evaluation should be guided by general criteria for growth insufficiency.
Abstract:
Growth problems are often seen in children with asthma. Rarely, these problems may be caused by poor asthma control. Negatively-deviating growth curves in asthmatic boys aged 8-15 years are often associated with a chronic delay in growth and puberty. Daily treatment with any dose of systemic corticosteroids suppresses the growth rate for as long as the treatment is maintained. The risk of growth rate suppression due to inhaled corticosteroids depends on the dose, administration regimen and delivery device. The risk becomes significant with > or =800 microg budesonide from a metered-dose inhaler with a spacer, and with > or =400 microg budesonide or fluticasone propionate from a dry-powder inhaler. Regardless of the treatment modality applied, all children with asthma should have their height growth measured at least every 6 months, and indications for endocrine work-up should follow general criteria for a growth-insufficient child.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma I: Introduction
Asthma III: Clinical Manifestations
